The final in a series on the need to formally prioritise patient input in HTA decision-making, we argue that the system currently lacks the ethical framework necessary to make morally defensible decisions. No system of decision-making can be considered ethical when its rules, when properly applied, lead to outcomes that delay access to treatment with consequent suffering, harm, and in some cases, death.
If the system properly applied results in harm, then the problem is worse than we think
November 20, 2025 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
LifeSciences Australia honours outstanding professionals at MTP Sector Awards 2026
June 12, 2026 - - Latest News -
'The changes could cause irreversible damage to our vibrant and world-leading biotech, medtech and health tech sector'
June 12, 2026 - - Australian Biotech -
The opportunity to change the conversation, the negotiating dynamic, and take some control
June 12, 2026 - - Latest News -
State and Territory ministers warn against centralising NDIS power
June 12, 2026 - - Latest News -
ARCS evolves into LifeSciences Australia as part of wider strategic change
June 11, 2026 - - Latest News -
Sigma confirms interest in the acquisition of UK pharmacy chain Boots
June 10, 2026 - - Latest News -
Island secures US partnership to advance Galidesivir dose study for Marburg
June 10, 2026 - - Australian Biotech

